European equities traded in the US as American depositary receipts were slightly higher late Wednesday morning, rising 0.3% to 1,347.42 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and telecommunications company VEON (VEON), which rose 0.5% and 1.3% respectively. They were followed by biotech firm BioNTech (BNTX) and internet browser company Opera (OPRA), which increased 1.6% and 1.7% respectively.
The decliners from continental Europe were led by biopharmaceutical company Genfit (GNFT) and oil and gas company TotalEnergies (TTE), which lost 3.3% and 3.8% respectively. They were followed by pharmaceutical company Ascendis Pharma (ASND) and electronics conglomerate Philips (PHG), which were down 0.6% and 1.1%, respectively.
From the UK and Ireland, the gainers were led by software firm Endava (DAVA) and financial services company Lloyds Banking Group (LYG), which advanced 2.4% and 3.2% respectively. They were followed by education company Pearson (PSO) and cruise line operator Carnival (CUK), which were up 3.3% and 1.9% respectively.
The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN), which fell 8%. They were followed by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Akari Therapeutics (AKTX), which dropped 0.5% and 1.5% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。